Featured Article
Finding effective ways to treat sepsis, is a big challenge for health centers. A clinical trial sponsored by the National Institutes of Health (NIH) has shown that acetaminophen reduces the risk of sepsis patients experiencing organ damage or developing acute respiratory distress syndrome.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Vaping Linked to Increased Lung Cancer Risk among Ex-Smokers
A large, population-based study carried out in Korea has shown that former smokers who use e-cigarettes, or vaping devices, are significantly more likely to develop or die from lung cancer than those who do not take up e-cigarette when they quit smoking.
Phenomix Test Identifies Ozempic and Wegovy Responders
A new test from Phenomix Sciences identifies responders to Ozempic and Wegovy, according to a study led by Mayo Clinic.
Acetaminophen Reduces Risk of Patients with Sepsis Having Organ Failure, Respiratory Distress
Finding effective ways to treat sepsis, is a big challenge for health centers. A clinical trial sponsored by the National Institutes of Health (NIH) has shown that acetaminophen reduces the risk of sepsis patients experiencing organ damage or developing acute respiratory distress syndrome.
